Position in AMGN
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$787,606
-$57,180 QoQ
Shares Held
2,175
-9.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
#1,861
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CARY STREET PARTNERS INVESTMENT ADVISORY LLC holds $10,872,180 across 13 Drug Manufacturers - General names. AMGN ranks #5 (7.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,853 | $3,421,967 | |
| 2 | ABBV |
AbbVie Inc.
|
9,052 | $2,277,835 | |
| 3 | JNJ |
Johnson & Johnson
|
5,727 | $1,454,479 | |
| 4 | MRK |
Merck & Co., Inc.
|
8,104 | $1,041,359 | |
| 5 | AMGN |
Amgen Inc
This page
|
2,175 | $787,606 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
3,702 | $467,705 | |
| 7 | NVS |
Novartis AG
|
2,406 | $377,067 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
6,072 | $349,863 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $787,606 | 2,175 | Shares | Other | 2026-07-17 | |
| 2026-03-31 | $844,786 | 2,401 | Shares | Other | 2026-04-29 | |
| 2025-12-31 | $653,962 | 1,998 | Shares | Other | 2026-02-09 | |
| 2025-09-30 | $531,942 | 1,885 | Shares | Other | 2025-11-10 | |
| 2025-06-30 | $411,270 | 1,473 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $424,327 | 1,362 | Shares | Other | 2025-05-09 | |
| 2024-12-31 | $107,903 | 414 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $3,946,748 | 12,249 | Shares | Defined | 2024-10-30 | |
| 2024-06-30 | $3,408,201 | 10,908 | Shares | Other | 2024-07-22 | |
| 2024-03-31 | $2,675,449 | 9,410 | Shares | Defined | 2024-04-30 | |
| 2023-12-31 | $2,660,727 | 9,238 | Shares | Other | 2024-02-07 | |
| 2023-09-30 | $2,325,847 | 8,654 | Shares | Other | 2023-11-13 | |
| 2023-06-30 | $1,867,410 | 8,411 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $2,036,985 | 8,426 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $2,147,869 | 8,178 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,799,142 | 7,982 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,396,055 | 5,738 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $351,364 | 1,453 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $267,714 | 1,190 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $270,490 | 1,272 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $313,706 | 1,287 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $313,998 | 1,262 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,206,850 | 5,249 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $2,568,795 | 10,107 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $296,947 | 1,259 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $284,227 | 1,402 | Shares | Sole | 2020-04-21 | |
| No filing history on record for this holder in this stock. | ||||||